Influencing factors for FibroTouch measurements in chronic hepatitis B patients based on liver pathology

Li ZhengXin; Chen YangYi; Zhao ZhiMin; Lyu Jing; Chen GaoFeng; Liu ChengHai

doi:10.3969/j.issn.1001-5256.2019.02.019

Volume 35 Issue 2

Feb. 2019

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2019 > 35(2): 338-344

PDF( 2015 KB)

Influencing factors for FibroTouch measurements in chronic hepatitis B patients based on liver pathology

DOI: 10.3969/j.issn.1001-5256.2019.02.019

Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Published Date: 2019-02-20

Abstract

Abstract

Objective To investigate the changes in positive staining of CD34, CK7, and CK19 and amount of fibrous collagen deposition in patients with chronic hepatitis B ( CHB) and the pathological basis affecting FibroTouch measurements. Methods A retrospective analysis was performed for the clinical data of 72 CHB patients who visited Department of Liver Cirrhosis in Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from January 2015 to December 2017. The amount of positive immunohistochemical staining of CD34, CK7, and CK19 was calculated, as well as the amount of fibrous collagen deposition in Masson trichrome staining and liver stiffness measurement ( LSM) by FibroTouch. The t-test was used for comparison of normally distributed continuous data between two groups. The Wilcoxon rank-sum test was used for comparison of non-normally distributed continuous data or continuous data with heterogeneity of variance between two groups. The chi-square test was used for comparison of categorical data between groups, and the Kruskal-Wallis H test was used for comparison of ranked data between multiple groups. The receiver operating characteristic ( ROC) curve was used to analyze the value of LSM in the diagnosis of hepatitis B cirrhosis, and the logistic regression model was used for multivariate analysis. Results With the increase in inflammation degree, there was no significant change in the amount of positive staining of CD34 ( P > 0. 05) , while there were significant increases in the amount of positive staining of CK19 and the amount of fibrous collagen deposition ( H = 9. 02 and 14. 12, P =0. 011 and 0. 001) . With the progression of liver fibrosis, there were significant increases in the amount of positive staining of CD34 and CK7 and the amount of fibrous collagen deposition ( H = 10. 26, 16. 29, and 22. 97, P = 0. 016, 0. 001, and < 0. 001) . The logistic regression analysis showed that the amount of positive staining of CK7 ( Wald = 4. 756, P = 0. 029) and the amount of fibrous collagen deposition ( Wald = 4. 757, P = 0. 029) were independent influencing factors for FibroTouch measurements. Conclusion Increases in the amount of fibrous collagen deposition and the amount of positive staining of CK7 may lead to increased FibroTouch measurements.
- hepatitis B, chronic,
- liver cirrhosis,
- FibroTouch,
- risk factors

FullText(HTML)

References(26)

References

[1]JIN CT, GUO LW, LIANG WF.Research progress on non-invasive serum markers for liver fibrosis assessment in patients with chronic hepatitis B[J/CD].Chin J Exp Clin Infect Dis:E-lectronic Edition, 2018, 12 (1) :11-14. (in Chinese) 金彩婷, 郭利伟, 梁伟峰.慢性乙型病毒性肝炎肝纤维化无创性血清诊断指标研究进展[J/CD].中华实验和临床感染病杂志:电子版, 2018, 12 (1) :11-14.

[2]SARIN SK, KUMAR M, LAU GK, et al.Asian-Pacific clinical practice guidelines on the management of hepatitis B:A 2015update[J].Hepatol Int, 2016, 10 (1) :1-98.

[3]VIZZUTTI F, ARENA U, ROMANELLI RG, et al.Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis[J].Hepatology, 2007, 45 (5) :1290-1297.

[4]de LDINGHEN V, WONG VW, VERGNIOL J, et al.Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement:Comparison between M and XL probe of FibroScan (R) [J].JHepatol, 2012, 56 (4) :833-839.

[5]CHON YE, CHOI EH, SONG KJ, et al.Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B:A meta-analysis[J].PLo S One, 2012, 7 (9) :e44930.

[6]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].JClin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[7]WANG TL, LIU X, ZHOU YP, et al.A semiquantitative scoring system for assessment of hepatic inflammation and fibrosis in chronic viral hepatitis[J].Chin J Hepatol, 1998, 6 (4) :5-7. (in Chinese) 王泰龄, 刘霞, 周元平, 等.慢性肝炎炎症活动度及纤维化程度计分方案[J].中华肝脏病杂志, 1998, 6 (4) :5-7.

[8]ABDALLA AF, ZALATA KR, ISMAIL AF, et al.Regression of fibrosis in paediatric autoimmune hepatitis:Morphometric assessment of fibrosis versus semiquantiatative methods[J].Fibrogenesis Tissue Repair, 2009, 2 (1) :2.

[9]BEDOSSA P.Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease[J].Hepatology, 2014, 60 (2) :565-575.

[10]STUECK AE, WANLESS IR.Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis[J].Hepatology, 2015, 61 (5) :1696-1707.

[11]THEISE ND, SAXENA R, PORTMANN BC, et al.The canals of Hering and hepatic stem cells in humans[J].Hepatology, 1999, 30 (6) :1425-1433.

[12]ROSKAMS TA, THEISE ND, BALABAUD C, et al.Nomenclature of the finer branches of the biliary tree:Canals, ductules, and ductular reactions in human livers[J].Hepatology, 2004, 39 (6) :1739-1745.

[13]LIN WR, LIM SN, MCDONALD SA, et al.The histogenesis of regenerative nodules in human liver cirrhosis[J].Hepatology, 2010, 51 (3) :1017-1026.

[14]YOON SM, GERSIMIDOU D, KUWAHARA R, et al.Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans[J].Hepatology, 2011, 53 (3) :964-973.

[15]FALKOWSKI O, AN HJ, IANUS IA, et al.Regeneration of hepatocyte'buds'in cirrhosis from intrabiliary stem cells[J].J Hepatol, 2003, 39 (3) :357-364.

[16]GUIDO M, SARCOGNATO S, SONZOGNI A, et al.Obliterative portal venopathy without portal hypertension:An underestimated condition[J].Liver Int, 2016, 36 (3) :454-460.

[17]OHBU M, OKUDAIRA M, WATANABE K, et al.Histopathological study of intrahepatic aberrant vessels in cases of noncirrhotic portal hypertension[J].Hepatology, 1994, 20 (2) :302-308.

[18]GUIDO M, SARCOGNATO S, RUSSO FP, et al.Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis[J].Liver Int, 2018, 38 (10) :1770-1776.

[19]DEFFIEUX T, GENNISSON JL, BOUSQUET L, et al.Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography[J].J Hepatol, 2015, 62 (2) :317-324.

[20]CASSINOTTO C, BOURSIER J, LEDINGHEN V, et al.Liver stiffness in nonalcoholic fatty liver disease:A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy[J].Hepatology, 2016, 63 (3) :1817-1827.

[21]SADLER MD, CROTTY P, FATOVICH L, et al.Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis[J].Can J Gastroenterol Hepatol, 2015, 29 (3) :139-144.

[22]RAMZY I, ELSHARKAWY A, FOUAD R, et al.Impact of old Schistosomiasis infection on the use of transient elastography (Fibroscan) for staging of fibrosis in chronic HCV patients[J].Acta Trop, 2017, 176:283-287.

[23]LENG XJ, YAN XB.Efficiency of FibroTouch in evaluating liver fibrosis degree in nonalcoholic fatty liver disease patients with different levels of body mass index[J].J Clin Hepatol, 2018, 34 (9) :1891-1895. (in Chinese) 冷雪君, 颜学兵.FibroTouch对不同BMI水平非酒精性脂肪性肝病患者肝纤维化程度的评估比较[J].临床肝胆病杂志, 2018, 34 (9) :1891-1895.

[24]LI JB, LIU S, WEN B, et al.Clinical significance of FibroTouch, ultrasound, and computed tomography in diagnosis of fatty liver disease:A comparative analysis[J].J Clin Hepatol, 2016, 32 (3) :459-462. (in Chinese) 李静波, 刘姝, 温博, 等.FibroTouch与B超、CT对脂肪肝的诊断价值比较[J].临床肝胆病杂志, 2016, 32 (3) :459-462.

[25]Review Panel for Liver Stiffness Measurement.Recommendations for the clinical application of transient elastography in liver fibrosis assessment[J].Chin J Hepatol, 2013, 21 (6) :420-424. (in Chinese) 肝脏硬度评估小组.瞬时弹性成像技术诊断肝纤维化专家意见[J].中华肝脏病杂志, 2013, 21 (6) :420-424.

[26]JIA J, HOU J, DING H, et al.Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B[J].J Gastroenterol Hepatol, 2015, 30 (4) :756-762.

Relative Articles

[1]	Jie YANG, Chengmao XIA, Zhe LIU, Meng ZHU, Yali SHE. Primary atypical epithelioid hemangioendothelioma of the neck of the gallbladder: A case report[J]. Journal of Clinical Hepatology, 2023, 39(7): 1678-1680. doi: 10.3969/j.issn.1001-5256.2023.07.023
[2]	Jintao SUN, Fengxia LI. Research advances in myosteatosis in chronic liver diseases[J]. Journal of Clinical Hepatology, 2023, 39(2): 444-449. doi: 10.3969/j.issn.1001-5256.2023.02.031
[3]	Qinghe ZENG, Yan MENG, Yuxiang LI. Research advances in cytomegalovirus hepatitis[J]. Journal of Clinical Hepatology, 2023, 39(6): 1431-1439. doi: 10.3969/j.issn.1001-5256.2023.06.028
[4]	Tianpeng ZHANG, Lihong YE, Hongxia GAO, Jinhong DONG, Chongkui WANG. Clinical and pathological features of drug-induced liver injury with different types of bile duct injury: An analysis of four cases[J]. Journal of Clinical Hepatology, 2023, 39(7): 1665-1672. doi: 10.3969/j.issn.1001-5256.2023.07.021
[5]	Shuli MA, Xiaoxi YANG, Chen CHEN, Jing YU, You ZHOU, Guotao LU, Xiaoxing XIANG, Weijuan GONG, Weiwei CHEN, Juan CHEN. Influencing factors for acute necrotizing pancreatitis in Eastern and Western countries: A meta-analysis[J]. Journal of Clinical Hepatology, 2023, 39(7): 1643-1656. doi: 10.3969/j.issn.1001-5256.2023.07.019
[6]	Yuanzhen WANG, Yaling YUN, Juan XIE, Liya HUANG. Value of five scoring systems in predicting the severity of hyperlipidemic acute pancreatitis: A comparative analysis[J]. Journal of Clinical Hepatology, 2023, 39(6): 1391-1397. doi: 10.3969/j.issn.1001-5256.2023.06.020
[7]	Hongsheng WU, Keqiang MA, Biling LIAO, Tengfei JI, Jianbin HUANG, Tiansheng CAO. Guiding effect of noninvasive monitoring of cardiac output and central venous oxygen saturation on early goal-directed fluid resuscitation in hyperlipidemic severe acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1602-1607. doi: 10.3969/j.issn.1001-5256.2022.07.026
[8]	Yuhang WENG, Qingfang XIONG, Duxian LIU, Xulei ZHANG, Yongfeng YANG. Clinical and pathological features of progressive familial intrahepatic cholestasis type 3[J]. Journal of Clinical Hepatology, 2022, 38(1): 154-159. doi: 10.3969/j.issn.1001-5256.2022.01.024
[9]	Suxian ZHAO, Shiheng LIU, Wencong LI, Fang HAN, Shuhong LIU, Qingshan ZHANG, Weiguang REN, Lingbo KONG, Na FU, Rongqi WANG, Li KONG, Yuemin NAN, Jingmin ZHAO. Clinical and pathological features of children with glycogen storage disease: An analysis of 10 cases[J]. Journal of Clinical Hepatology, 2022, 38(8): 1839-1842. doi: 10.3969/j.issn.1001-5256.2022.08.022
[10]	Yan WANG, Mingzheng LI, Yufeng LIU, Shiming WANG. Early predictors for acute kidney injury in acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(5): 1192-1197. doi: 10.3969/j.issn.1001-5256.2022.05.046
[11]	Yuchuan LI, Yi LU, Jiayan FENG, Jianshe WANG. Clinical and genetic features of patients with glycogen storage disease type Ⅸa: An analysis of 20 cases[J]. Journal of Clinical Hepatology, 2021, 37(2): 380-384. doi: 10.3969/j.issn.1001-5256.2021.02.026
[12]	Yongfeng YANG. Pathological features and pathological diagnosis of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2021, 37(11): 2530-2533. doi: 10.3969/j.issn.1001-5256.2021.11.005
[13]	Cheng JieYao, Wang CangHai, Chen JianHong, Ding PengPeng, Du XueMei, Li Li, Wang YaDan, Wei Nan, Liu Hong. Sarcomatoid carcinomas of the liver,gallbladder,and pancreas: A clinicopathological portrait and literature review[J]. Journal of Clinical Hepatology, 2020, 36(10): 2270-2273. doi: 10.3969/j.issn.1001-5256.2020.10.022
[14]	Peng XiaoQian, Liu Lu, Jiao XiaoXiao, Zhou Lin. Clinicopathological features and prognosis of periampullary carcinomas in the pre-jaundice stage[J]. Journal of Clinical Hepatology, 2019, 35(12): 2748-2753. doi: 10.3969/j.issn.1001-5256.2019.12.022
[15]	Gui Yang, Sun JunJun, Yang YanHui, Liu WeiFeng, Yang TianBao, Chu ZhiJie, Yang Cheng, Wang Du, Liu JiangBo. Effect of bilateral greater splanchnic nerve transection on hepatic injury in dogs with acute necrotizing pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1733-1739. doi: 10.3969/j.issn.1001-5256.2018.08.028
[17]	Yang Yang, Fan HaiNing, Deng Yong. The role of epithelial-mesenchymal transition in gastrointestinal cancer and fibrosis[J]. Journal of Clinical Hepatology, 2012, 28(4): 312-315.
[18]	Miao YaJiao, Zhao ShouSong. Advances in soluble HLA-Ⅰ[J]. Journal of Clinical Hepatology, 2011, 27(9): 991-994.
[19]	Zhang HuiJing, Li ShengMian. Promoter methylation in APC, RASSF1A, WIF-1 gene in digestive system tumors[J]. Journal of Clinical Hepatology, 2011, 27(4): 429-432.
[20]	Yu Xia, Sun Qian, Zhang Yi. PI3K/Akt/mTOR signal transduction pathway and digestive system tumors [J]. Journal of Clinical Hepatology, 2010, 26(4): 446-449.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	闫瑞振，窦一峰. 基于多元线性回归方程模型的天津市某三甲医院骨科住院患者费用及其影响因素分析. 医学信息. 2024(02): 41-46 .
2.	孙瑜婧. 奥曲肽联合乌司他丁治疗急性胰腺炎患者的临床研究. 中国临床药理学杂志. 2024(18): 2650-2654 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1803) PDF downloads(298)

Influencing factors for FibroTouch measurements in chronic hepatitis B patients based on liver pathology

DOI: 10.3969/j.issn.1001-5256.2019.02.019